EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Synthesis and Evaluation of 99m Tc Essential Analogue of DUPA PSMA Inhibitor for Its Potential Use in Prostate Cancer Imaging

Navin Sakhare, Sheela Muralidharan, Dheeraj Kumar, Shubhankar Dutta, Rani Gnanasekar, Shalaka Paradkar, Arpit Mitra, Bhabani Mohanty, Shubhangi Mirapurkar, Anupam Mathur, Pradip R. Chaudhari, Kakoli Bose

ChemistrySelect · 2026-06 · 11 (21)

DOI: 10.1002/slct.202506967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 27.05.2026. Verfasst von Navin Sakhare und 11 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DUPA (2‐[3‐(1,3‐dicarboxy propyl) ureido] pentanedioic acid) is a known small molecule prostate‐specific membrane antigen (PSMA) enzyme inhibitor that targets the PSMA receptor found overexpressed on prostate cancer. The present work synthesizes and evaluates a 99m Tc (technetium) “metal essential” glutamate complex, which mimics the DUPA ligand, for its potential use in SPECT imaging of PSMA‐positive prostate cancers. Glutamic acid was synthetically modified on treatment with carbon disulfide in the presence of sodium carbonate to yield glutamate‐dithiocarbamate (gDTC) in moderate yields (∼60%). To a freshly prepared [[ 99m Tc]Tc≡N] 2+ intermediate, gDTC was added to yield the final complex in high radiochemical yield and purity (>95%). The complex was then bio‐evaluated in vitro in PSMA‐positive LNCaP cell lines in comparison to the standard [ 177 Lu]Lu‐PSMA‐617 tracer. [ 99m Tc]Tc‐analogue of DUPA ligand showed uptake in LNCaP cells (∼9.5%ID/10 6 cells @ 2 h; K d ∼ 25.2 ± 6.2 nM) in comparison to [ 177 Lu]Lu‐PSMA‐617 (∼5%ID/10 6 cells @ 2 h), however the percentage specificity observed was only 60% (vs. 90% for [ 177 Lu]Lu‐PSMA‐617) as ascertained from inhibition using 2‐PMPA (blocker). The in vivo distribution in normal Sprague‐Dawley (SD) rats indicated similar pharmacokinetics as that observed for [ 177 Lu]Lu‐PSMA‐617. The [ 99m Tc]Tc‐radiotracer showed high retention in the kidneys as observed for several radiolabeled PSMA analogues.

Zitieren

APA

Sakhare, N., Muralidharan, S., Kumar, D., Dutta, S., Gnanasekar, R., Paradkar, S., Mitra, A., Mohanty, B., Mirapurkar, S., Mathur, A., Chaudhari, P. R., & Bose, K. (2026). Synthesis and Evaluation of 99m Tc Essential Analogue of DUPA PSMA Inhibitor for Its Potential Use in Prostate Cancer Imaging. ChemistrySelect, 11(21). https://doi.org/10.1002/slct.202506967

Vancouver

Sakhare N, Muralidharan S, Kumar D, Dutta S, Gnanasekar R, Paradkar S, et al. Synthesis and Evaluation of 99m Tc Essential Analogue of DUPA PSMA Inhibitor for Its Potential Use in Prostate Cancer Imaging. ChemistrySelect. 2026;11(21). doi:10.1002/slct.202506967

BibTeX
@article{Sakhare2026,
  author = {Sakhare, Navin and Muralidharan, Sheela and Kumar, Dheeraj and Dutta, Shubhankar and Gnanasekar, Rani and Paradkar, Shalaka and Mitra, Arpit and Mohanty, Bhabani and Mirapurkar, Shubhangi and Mathur, Anupam and Chaudhari, Pradip R. and Bose, Kakoli},
  title = {Synthesis and Evaluation of 99m Tc Essential Analogue of DUPA PSMA Inhibitor for Its Potential Use in Prostate Cancer Imaging},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {21},
  doi = {10.1002/slct.202506967}
}
Kostenlos starten →